News und Veranstaltungen
Adamant Health wird von Hello Tomorrow als Deep Tech Pionier ausgewählt
Adamant Health wurde von Hello Tomorrow aus 4.600 Bewerbungen aus 120 Ländern als Deep Tech Pioneer ausgewählt. Hello Tomorrow ist das größte Netzwerk von Deep Tech Startups, Investoren und den innovativsten privaten und öffentlichen Organisationen, die Deep Tech Startups und Unternehmen beim Aufbau neuer Lösungen unterstützen.
WANTED: Data Analyst & Scientist (Biosignal analysis)
Adamant Health is growing and entering a new phase in its journey, and we are now looking for a person to work as a Data Analyst & Scientist for the company. In this role, you will analyze the data measured from the patient with our leading measurement and analysis service and create symptom reports used by our customers.
Neues Patiententagebuch für den Adamant Health Mess- und Analyseservice
Das neue, speziell für den Adamant Health Mess- und Analyseservice entwickelte Patiententagebuch bietet eine einfache und sichere Möglichkeit, genaue Informationen über die Medikamenteneinnahme, die Symptome und das Wohlbefinden des Patienten für den klinischen Gebrauch zu sammeln.
Adamant Health für AMPlify - Beschleunigter US-Markteintritt Programm 2024 ausgewählt
Wir sind stolz darauf, dass Adamant Health eines von zwölf ausgewählten finnischen Gesundheitsunternehmen für das Programm AMPlify - Accelerated US Market Entry 2024 ist. Das von Business Finland in Zusammenarbeit mit der Mayo Clinic entwickelte Programm zielt darauf ab, finnische Gesundheitsunternehmen beim Zugang zum US-Markt zu unterstützen und ihre Markteinführungszeit zu verkürzen.
Adamant Health in das NOME-Programm aufgenommen
Adamant Health wurde für das US MedTech-Programm 2024 des Nordic Mentor Network For Entrepreneurship ausgewählt. Die Aufnahme von Adamant Health in das Programm ist ein Beweis für unsere bahnbrechende Forschung und hochmoderne Technologie. Wir freuen uns auf die Zusammenarbeit mit den erstklassigen Mentoren, die aus den besten Life-Science-Experten in den nordischen Ländern und den USA ausgewählt wurden.
Anne Fraser-Vatto appointed as new Director, Finance and Operations
Anne Fraser-Vatto has joined the Adamant Health team as the new Director, Finance & Operations. Anne has over 20 years of experience in finance and operations, including with international growth companies.
10x health technology from Finland
Tekniikan Maailma features ten Finnish health technology companies providing innovative solutions for the benefit of the patient – Adamant Health with its unique measurement and analysis service for Parkinson's disease being one of them.
WANTED: Director of Finance and Operations
As the Director of Finance and Operations, you will play a critical role in shaping the financial and operational strategies of Adamant Health. This position offers a unique blend of financial management and operational involvement, making it ideal for those who thrive in a dynamic and evolving environment.
World Parkinson's Day 2024
Today is World Parkinson's Day, a day dedicated to raising awareness for the disease and paying tribute to people living with the condition every day! Parkinson’s disease is the fastest-growing neurological disorder in the world, affecting people of all races and cultures.
Parkinson's Awareness Month 2024
April marks Parkinson’s Awareness Month, a time dedicated to increasing awareness about and elevating the conversation around Parkinson's disease, a neurological disorder that progressively impairs movement and function, affecting millions worldwide.
Bringing research to the benefit of people suffering from Parkinson’s disease
On Saturday, we had the honor to celebrate the Finnish Movement Disorders Association’s 40th anniversary together with over 200 guests, including people diagnosed with movement disorders and their relatives.
Wanted: Software Developer – Cloud backend
Are you passionate about software development? Do you seek a meaningful job to help people suffering from Parkinson’s disease? We are looking for a Software Developer to join our diverse and passionate team of professionals to revolutionize the care of Parkinson's disease.
Season's greetings 2023
2023 has been an exciting year for Adamant Health. With the year drawing to an end, we’d like to take this opportunity to thank you for your cooperation and support. As we pause to spend time with family and friends during the holidays, we wish you a happy, healthy holiday season and a wonderful New Year!
World Movement Disorders Day 2023
Movement disorders can be especially difficult to diagnose, treat, and understand. In the next 30 years, there will be a strong increase in the number of people affected by movement disorders and that is why we are promoting #MoveDisorder awareness.
New study on wearable monitoring of negative myoclonus available
A new study on wearable monitoring of negative myoclonus within the home environment is now available. The research was conducted in collaboration between the University of Eastern Finland, Kuopio University Hospital (KUH) - Kuopion yliopistollinen sairaala (KYS), UCL Queen Square Institute of Neurology and Adamant Health.
Adamant Health has developed a unique method for measuring the symptoms of Parkinson's patients
Adamant Health has developed a technology and service that will revolutionize the care of Parkinson's disease and other movement disorders. Business Kuopio has interviewed Adamant Health's founders Paulus Carpelan and Saara Rissanen.
Gesucht: Software-Entwickler - Mobile
Adamant Health is growing and entering a new phase in its journey, and we are looking for a Software Developer to strengthen our team. In this role you are developing mobile applications enabling our unique Parkinson’s disease measurement, connecting data to our cloud service, and communicating analyzed information back to the patient.
Adamant Health selected for Deep Tech Accelerator funding program
Adamant Health secures funding from Business Finland's Deep Tech Accelerator program for rapid market entry and targeted growth on international markets. The Deep Tech Accelerator funding will serve as a catalyst in accelerating Adamant Health's entry to selected European markets and drive our growth, particularly within our target customer segments.
Adamant Health’s project co-funded by the European Union
Adamant Health’s project focusing on better understanding Parkinson’s disease patients’ lives at home is co-funded by the European Union.
Adamant Health team is growing
After several successful recruitments during spring 2023, Adamant Health's team has been growing. Meet our team of 14 professionals dedicated to revolutionise the care of Parkinson's disease!
Newsletter
Wir halten Sie über unsere neue Technologie, Veranstaltungen und weitere Neuigkeiten auf dem Laufenden.